In focusing on Braun, Major League Baseball is abandoning the principles of its drug testing/enforcement program

36 Comments

Been doing some more thinking about the story this morning about how Major League Baseball is laser-focused on Ryan Braun in the Biogenesis investigation, to the point where it is considering giving players immunity in an effort to nab him and some of the bigger fish.

As a basic premise, I don’t have a real problem with that. This is how police work is usually done: get the small fish to flip on the big fish and so forth. I think this differs from the organized crime analogy in that here the “big fish” is only one player whose violation is no different in kind or magnitude than that of any other person cheating — and, as such, going after Braun like this is likely to cause MLB to overlook multiple more cheaters who collectively represent a greater ill to baseball than one more famous cheater — but that’s their prerogative. If they get the goods on Braun and punish him, fine, he’s punished.

All of that said, in pursuing things in such a way it’s inescapable that Major League Baseball is abandoning some of the core principles of the drug program as currently constructed.

For one thing: zero tolerance. The most adamant anti-PED folks on the planet, including WADA and USADA have spent decades telling us that zero tolerance is critical to any drug testing regime and that only through zero tolerance can you have a level competitive landscape. In singling out Braun, however, and standing willing to grant immunity to some players in order to get him, Major League Baseball is abandoning that principle. It is saying that some cheaters are more important than others. Which is the same as saying that some cheating will, in effect, be tolerated and will go unpunished.

And maybe Major League Baseball is fine with that. If so, they should say so. And if so they should cease selectively applying the standards of zero tolerance. I mean, if MLB is satisfied that it can weigh the words and determine the truthfulness of one player’s word over another’s and that it can mete out differential enforcement like this and not harm the very essence of the Joint Drug Agreement, surely it can listen to defenses of inadvertent contamination and accidental ingestion of various stimulants and PEDs, can it not? Now Bud Selig says that it can’t do that for risk of imperiling zero tolerance principles. But if the Biogenesis investigation throws such principles over the side, what is left to protect?

Also being abandoned right now: the anonymity of the testing and enforcement process.  Major League Baseball’s fixation on Braun is of such a high pitch, it appears, that it was deemed unique and newsworthy by someone privy to the process and thus was leaked to Bob Nightengale of USA Today. Since when is that acceptable? The last time news of a drug investigation/enforcement proceeding was made public it led to MLB being publicly embarrassed when that outfielder from Milwaukee beat the rap. How did that turn out for you, Mr. Selig? And how has it turned out for that outfielder, whose name will always be mud to some folks regardless of what the future holds?

If Ryan Braun cheated — and if Major League Baseball can prove it — yes, he should absolutely be punished. And at this point, if what Nightengale is reporting is true, I’d lay better odds on Braun getting popped than him getting off.  But in getting that head on a platter it’s inescapable that Major League Baseball is transforming its drug testing and enforcement regime from a clinically-based program into a police operation.  And in doing so, it appears willing to abandon zero tolerance, anonymity, uniform enforcement and everything the league tells us is so good about the Joint Drug Agreement in the first place.

Hope it’s worth it, guys.

Johnny Cueto expected to opt-out of his deal after the season

Getty Images
1 Comment

Johnny Cueto signed a six-year $130 million deal with the Giants prior to the 2016 season. In his first season he went 18-5 with a 2.79 ERA and 198 strikeouts in 219.2 innings, helping lead the Giants to the playoffs. This season has been rocky for Cueto — he’s got a a 4.42 ERA in 15 starts and has battled blisters — but they’ve been far rockier for the Giants overall, as they sit in last place in the NL West and have the second worst record in baseball.

Many suspect that the Giants will either rebuild or, at the very least, restructure some in response to this nightmare year. If so, they’re likely going to be doing it with Cueto, who Jon Heyman reports is going to opt-out of his deal:

San Francisco Giants starting pitcher Johnny Cueto is planning to opt out of his contract at the end of the year, but he would listen to any extension offer . . . Cueto has $84 million to go over four years. It would probably take an injury or major slump for Cueto not to opt out. But it makes sense that he will.

Heyman says the Giants are not inclined to give him an extension, so expect to see Cueto on the free agent market three days after the World Series ends, which is the deadline for him to exercise his opt-out rights.

The Dodgers are concerned about Julio Urias’ shoulder

Getty Images
2 Comments

Things are going great for the Dodgers lately. They’ve won seven consecutive games and 13 of their last 14. They lead the National League in wins and are in first place in, arguably, the best division in baseball.

But there are a lot of moving parts on a baseball team, and even when some things are going great, other things can go not-so-great. Like this:

Urias has been diagnosed with shoulder inflammation and shut down indefinitely. An MRI last week showed no structural damage, but his shoulder is still bothering him. He has not pitched in the bigs since late May, when he allowed seven runs in less than three innings against the Miami Marlins. He was sent down after that and went 3-0 with a 3.12 ERA, six walks and 17 strikeouts in 17.1 innings pitched in three starts with Oklahoma City before being shelved.